Generated by GPT-5-mini| Kidney International | |
|---|---|
| Title | Kidney International |
| Discipline | Nephrology |
| Abbreviation | KI |
| Editor | Pierre-Yves Martin |
| Publisher | Nature Portfolio |
| History | 1972–present |
| Frequency | Monthly |
| Impact factor | 20.0 |
Kidney International is a peer-reviewed medical journal covering clinical and translational research in Nephrology, Renal physiology, Renal pathology, and related fields. Founded in the early 1970s, it publishes original research, reviews, clinical trials, and guidelines that intersect with organizations such as the International Society of Nephrology, American Society of Nephrology, European Renal Association–European Dialysis and Transplant Association, and major academic centers like Mayo Clinic, Massachusetts General Hospital, and Johns Hopkins Hospital. The journal serves investigators working on topics ranging from chronic kidney disease research at National Institutes of Health laboratories to transplantation studies from centers like Cleveland Clinic and Oxford University Hospitals.
The journal was established during a period of expansion in nephrology publishing alongside titles such as The New England Journal of Medicine items on renal failure and specialty outlets affiliated with societies including the International Society of Nephrology and the American Society of Nephrology. Early editorial leadership included figures associated with institutions like Mount Sinai Health System, University of Pennsylvania, and Stanford Health Care, which fostered links to research programs at NIH and multinational collaborations with groups from Karolinska Institutet, University of Toronto, and University of Barcelona. Over decades the journal tracked milestones such as the adoption of hemodialysis standards influenced by consensus conferences at World Health Organization forums and pivotal transplant immunology advances related to work at Fred Hutchinson Cancer Center and University of California, San Francisco.
The editorial board historically reflects leaders from academic centers including Harvard Medical School, University of Oxford, Université de Paris, Kyoto University, and Charité – Universitätsmedizin Berlin. Production and distribution are handled by Elsevier-era transitions into Nature Portfolio publishing channels, with manuscript handling involving peer reviewers drawn from networks at Imperial College London, University of Melbourne, and Seoul National University Hospital. The journal issues monthly volumes, manages electronic archives linking to repositories like PubMed Central and indexing services including Science Citation Index, Scopus, and MEDLINE. Policies on ethics and data-sharing reference standards from bodies such as the International Committee of Medical Journal Editors and the Committee on Publication Ethics.
Content spans basic science contributions from laboratories at institutions such as Salk Institute and Max Planck Society units, clinical trials sponsored by consortia involving European Medicines Agency and Food and Drug Administration (United States), and epidemiologic reports utilizing cohorts from Framingham Heart Study-related collaborations and national registries like the United States Renal Data System. Topics include mechanistic studies tied to signaling pathways investigated at Cold Spring Harbor Laboratory, biomarker discovery in partnership with centers like Broad Institute, dialysis technology development from engineering groups at Massachusetts Institute of Technology, and transplant immunogenetics informed by work at Stanford University School of Medicine.
The journal’s influence is reflected in citation metrics tracked in Journal Citation Reports and usage statistics from aggregators like Altmetric and institutional subscriptions at libraries of Yale University, Princeton University, and University of California. High-impact articles have informed clinical practice guidelines issued by organizations such as the National Kidney Foundation, Kidney Disease: Improving Global Outcomes, and regulatory decisions recorded by the European Medicines Agency. Bibliometric analyses published in venues like PLOS ONE and The Lancet have compared the journal’s performance to peers including Clinical Journal of the American Society of Nephrology and American Journal of Kidney Diseases.
Seminal papers published in the journal include landmark reports on electrolyte disorders cited alongside classic studies from Royal Free Hospital and mechanistic discoveries that built on work at University College London and Weill Cornell Medicine. Supplements and special issues have gathered consensus statements produced with stakeholders such as the World Health Organization, trial protocols coordinated by groups at Vanderbilt University Medical Center, and position papers co-authored by committees from the International Society of Nephrology and the European Renal Association–European Dialysis and Transplant Association.
The journal maintains formal and informal relationships with professional societies including the International Society of Nephrology, the American Society of Nephrology, and the European Renal Association–European Dialysis and Transplant Association. Collaborations extend to academic partners like University of Washington, University of Michigan, Peking University Health Science Center, and philanthropic funders such as the Bill & Melinda Gates Foundation for global kidney health initiatives.